Non-small cell lung cancer
Conditions
Sponsors
Department of Pathology, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Non-small cell lung cancer was diagnosed by pathological biopsy; 2. R0 Surgical resection was proposed; 3. Postoperative TNM stage was Ib, III -N2 and M1a with thoracic implant metastasis; 4. Informed consent of patients or their entrusted agents.
Exclusion criteria
Exclusion criteria: 1. Preoperative chemotherapy, radiotherapy or other anti-tumor treatment; 2. Patients with other serious complications can not tolerate surgery; 3. Patients with other types of malignancies; 4. Patients who died within one month after surgery; 5. Patients who failed to complete adjuvant therapy according to the NCCN guidelines for various reasons after surgery; 6. After signing the consent, the patient and the agent requested to withdraw from the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immunoscore; | — |
Secondary
| Measure | Time frame |
|---|---|
| tertiary lymphoid structures;ctDNA;Lung cancer 58 gene; | — |
Countries
China
Contacts
Public ContactLili Jiang, Daxing Zhu
Department of Pathology, West China Hospital, Sichuan University
Outcome results
None listed